Ss&C Technologies Stock Price, News & Analysis

SS&C Technologies (Nasdaq: SSNC) announced the extension of its partnership with Ninety One, a global investment manager, on August 2, 2021. Ninety One has retained SS&C's Global Investor and Distribution Solutions (GIDS) to provide transfer agency services for its U.K. business. This collaboration aims to enhance digital investor engagement and analytics capabilities for the Ninety One Fund Managers U.K. Limited. Both companies expressed satisfaction with the ongoing partnership focused on growth and improved service delivery.

SS&C Technologies Holdings, Inc. (SSNC) reported strong financial results for Q2 2021, achieving a 10.6% increase in revenue to $1,259.0 million and a 29.7% rise in operating income of $312.9 million compared to Q2 2020. Adjusted diluted earnings per share increased by 10.9% to $0.71. The company announced a $1 billion stock repurchase program and generated $562.3 million in cash from operating activities for the first half of 2021. Guidance for Q3 2021 forecasts adjusted revenue of $1,205.0 to $1,245.0 million.

SS&C Technologies Holdings reported a rise in its GlobeOp Forward Redemption Indicator for June 2021, at 2.68%, up from 2.46% in May. For July, the indicator is at 1.81%, the lowest July figure since 2008 and down from 2.64% in the same month last year. This decline indicates strengthened confidence among hedge fund investors, as evidenced by significantly lower redemptions since a peak of 19.27% in November 2008. The next report is scheduled for August 20, 2021.

SS&C Technologies (Nasdaq: SSNC) announced a joint venture named DomaniRx to develop a cloud-native, API-driven claims adjudication platform. This initiative aims to enhance Pharmacy Benefit Management (PBM) by improving the user experience for both payers and providers. The platform promises affordable and transparent solutions utilizing open-source technology and advanced analytics. Humana will be the first customer, indicating strong industry interest. The collaboration underscores SS&C's commitment to innovation and leveraging its technology capabilities in the healthcare sector.

SS&C Technologies announced the launch of its ALPS | Hillman Active Value ETF (HVAL), an actively managed large-cap value ETF. This fund aims to deliver long-term returns through a strategy focused on identifying undervalued businesses with sustainable competitive advantages. The investment process includes rigorous fundamental analysis and daily disclosure of holdings. The ETF is designed to be tax-efficient and low-cost, making it accessible for a wider range of investors. The firm has $18.5 billion under management as of June 30, 2021.

SS&C Technologies announced a significant upgrade to its SS&C Chorus intelligent automation platform with the release of Chorus BPM 21.1. The upgrade aims to enhance straight-through processing and operational efficiency across financial services and healthcare sectors.

Key features include low-code design capabilities, new data automation functions, improved user experience, and advanced Quality Check AI to enhance accuracy and reduce errors. This upgrade reflects SS&C's ongoing investment in Intelligent Automation, allowing for quick deployment and efficiency gains for its global client base.